Prosthetic Heart Valve Market - Industry Size, Growth Factors, Top Leaders, Development Strategy, Future Trends, Histori

Prosthetic Heart Valve Industry 2019 Global Market research report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market.


The American Heart Association estimates that approximately 13.7 people per 1, 000 are affected by bicuspid aortic valve defects in the U.S. The growing cases of valve regurgitation and heart diseases, further leads to the ever increasing demand for heart valve devices. It, in turn, propels the global prosthetic heart valve market during the forecast period. Fortune Business Insights, in an upcoming report, titled, “Prosthetic Heart valve Market Size, Share and Global Trend By Product Type (Repair Products, Replacement Products), By Technology (Mechanical Valve, Biological Valve, Decellularized valve), By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and Geography Forecast till 2026,” mentions that favourable reimbursement policies across the world is expected to drive the global prosthetic heart valve market sales in the coming years. The report strategically analyzes the global prosthetic heart valve market concerning contributions, prospects, and growing trends happening in the market.

Request a Sample Copy of the Research Report:

Increasing Prevalence of Heart Diseases to Favor Growth in Asia Pacific and Europe

The global prosthetic heart valve market is geographically divided into Latin America, Asia Pacific, Europe, the Middle East and Africa, and North America. Amongst these regions, North America is expected to exhibit high growth of the prosthetic heart valve market share during the forecast period. Technological advancement in this field is the main reason for the growth, which is likely to increase the demand for heart valves. The American Heart Association stated that more than 26,000 transcatheter aortic valve replacements were performed in the U.S., between the period of 2011 to 2014. It proves that the prosthetic heart valve market in North America is persistently growing and would continue to do so.

In Asia Pacific and Europe, the prosthetic heart valve market is projected to show an astonishing CAGR by 2025 due to the growing number of innovative product launches by several key market players as well as the rising incidence of heart diseases. In the Middle East and Africa and Latin America, the market is likely to grow due to the increasing prevalence of cardiac diseases.

For more information visit :

Boston Scientific, Meril, and Edwards Focus on Product Launches and Fast Track Approvals to Increase Sales

Boston Scientific, a manufacturer of medical devices used in oncology, cardiac surgery, urology, and others, headquartered in the U.S., announced in April 2019 that the FDA approved its Lotus Edge transcatheter aortic valve system in April 2019. The transcatheter aortic valve system technology is meant to treat those patients who are suffering from severe aortic stenosis as well as those who are at greater risk for surgical valve replacement. It is delivered through a minimally invasive procedure. The Lotus Edge valve system is considered to be the only FDA-approved product that offers physicians to completely recapture and reposition the valve after deploying. It is the third valve to enter the market in the U.S. Lotus Edge also features an adaptive seal and a braided wire valve frame.

Meril Life Sciences, a global medical device manufacturer, based in the U.S., introduced itsnew indigenouslydeveloped and manufactured artificial aortic valve in December 2018. It will aid those patients who are hesitant to go through open-heart valve replacement surgery and those who are at higher risk. The valve will be sold under the name “Myval” and it would be a minimally invasive procedure. The doctor would insert a catheter through the patient’s femoral artery to put an artificial valve in the diseased valve.

Edwards Lifesciences Corporation, a medical equipment company specializing in hemodynamic monitoring and artificial heart valves, headquartered in the U.S., declared in October 2018 that the FDA approved its study of CENTERA transcatheter valve for patients suffering from symptomatic and symptomatic aortic stenosis (AS). It is a self-expanding transcatheter. The multi-center, single-arm, and prospective study is anticipated to register around 1,000 patients. It also includes bicuspid enrollment.

Fortune Business Insights has profiled some of the prominent market players operating in the global prosthetic heart valve market. They are as follows:

  • CyroLife Inc.
  • Mitralign Inc.
  • Medtronic
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Corlife
  • Abbott
  • Edwards Lifesciences Corporation
  • ON-X Life Technologies Inc.
  • Other key market players

Related Reports:

CMOS X-ray Detectors Market – Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Size Analysis by Forecast to 2026 | Market Reports World


Medullary Thyroid Cancer Treatment Market Global Industry Growth, Historical Analysis, Size, Trends, Emerging Factors, Demands, Key Players, Emerging Technologies and Potential of Industry Till 2026

gostearn is the code name for a secret society of people closely connected with the cryptocurrency world – freelance services from $10

Invest Funds Online is a modern investment company with lucrative techniques and tools. We help thousands of people meet their current expenditure needs